VCJ Staff

Barosense Raises $30 Million

HLM Venture Partners Raising $200 Million

Shawn Singh Names VistaGen CEO

Shawn Singh has joined VistaGen Therapeutics as CEO. He previously was managing principal of Cato BioVentures, a VistaGen investor.

Amyris Biotech Raising Series C Round

Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has secured $24.75 million of a $62 million Series C round, according to a regulatory filing. The company previously raised more than $120 million, from firms like Khosla Ventures, Kleiner Perkins Caufield & Byers, DAG Ventures and TPG Biotech. www.amyrisbiotech.com

Syndiant Raises $10.7 Million

Syndiant, a Dallas-based maker of light modulating chips used in ultra-portable projectors, has raised $10.7 million in Series B funding. Backers include the Texas Emerging Technology Fund and individual angels.

Bosch Buying Akustica

VC-Backed Bust: Sequoia Communications

Going Private "Like Having A Tattoo Removed, Layer By Layer"

CallWave was delisted from the Nasdaq on June 30 and re-emerged today as Fuze Box, after settling two lawsuits from dissident shareholders and battling two hostile takeover attempts, according to CEO Jeff Cavins. Also, Cavins is still recovering from a case of pneumonia. "Taking a company private is like having a tattoo removed -- incredibly painful," he said. "Once you get on the other side, you don't have time to celebrate. You're so exhausted, and you've got a business to run." Cavins joined CallWave a couple of years ago after the company went public -- in 2004 -- with an Internet telephony product for people who still used dial-up to get online. The product would route phone calls to your computer screen if you were surfing the Web and then back to your phone if you wanted to talk.

Urgent Career Raises Series A

Urgent Career, a New York-based based provider of tools for assessing sales professionals, has raised an undisclosed amount of Series A funding from iNovia Capital.

Coherex Medical Raises $16.5 Million

Coherex Medical Inc., a Salt Lake City-based developer of medical devices that can help close certain heart defects, has raised $16.5 million in Series B funding. Return backers Oxford Bioscience Partners and vSpring Capital co-led the round, with Tullis Health Investors also participating.